Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma

Fig. 1

a The panel shows the significant correlation between the size of tumor and the VEGF-121 plasma level in the xenografts (linear regression, r2 = 0.9450; p = 0.0001); b. The panel shows the significant reduction of the human VEGF-121 plasma level in rats harboring intracranial xenografts of human GB U87MG cell line, between controls and bevacizumab-treated animals (p = 0.0004 Mann-Whitney t test t)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us